Kwangmeyung J. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 296 publications
Injectable Optoelectronic Probe With In Situ Photoactivation and ROS Monitoring for Oxygen-Dependent Metronomic Photodynamic Cancer Therapy.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 27, 2026
Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 30, 2025
Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
Journal: Theranostics
Published: December 24, 2025
Switching tumor-derived extracellular vesicles off and on via targeted proteolysis to shift toward immunogenic phenotypes.
Journal: Signal transduction and targeted therapy
Published: December 11, 2025
Nanodiscs embedded with μ-opioid receptors as decoy receptors to reverse opioid overdose.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 10, 2025
Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.
Journal: Journal of nanobiotechnology
Published: December 05, 2025
Nanotechnology-based strategies for overcoming clinical limitations of PROTACs in cancer therapy.
Journal: Journal of materials chemistry. B
Published: September 26, 2025
High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity.
Journal: Asian journal of pharmaceutical sciences
Published: September 07, 2025
Cathepsin B-Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer-Specific Immunogenic Cell Death and Minimizing Systemic Toxicity.
Journal: Advanced healthcare materials
Published: September 07, 2025
Effective Degradation of Wild-Type and Mutant EGFR Using Self-Assembling Peptide-Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 30, 2025
Perspectives and trends in gas delivery systems based on ultrasound responsive nanomaterials for cancer therapy.
Journal: Advanced drug delivery reviews
Published: August 13, 2025
Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy.
Journal: Signal transduction and targeted therapy
Published: May 27, 2025
Last Updated: 09/26/2026